Anavex Life Sciences Corp (AVXL)

[Investor2014]

Highly statistically significant / small p-values alone doesn’t tell us how large and clinically meaningful the reduction in volume loss is.

The reduction could be very small but consistently so versus placebo and achieve great p-values.

My question is why does Anavex just release a p-values range, but not absolute numbers of reduction in brain volume loss and by brain region?

Same nonsense as with the naked odds ratios. It amounts to bs and the market seems to understand that quite well!